Development of a Personalized Intervention to Motivate Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
The clinical trial, sponsored by Rhode Island Hospital, focuses on developing a personalized intervention to motivate health behavior changes in midlife adults at risk for Alzheimer's disease. This initiative addresses a significant unmet need in the Alzheimer's prevention market, targeting a demographic that is increasingly aware of lifestyle factors influencing cognitive health. The intervention's dual approach—basic and enhanced education—positions it competitively against existing lifestyle modification programs. Given the rising prevalence of Alzheimer's disease, successful outcomes could lead to partnerships with healthcare providers and potential integration into preventive health strategies, enhancing market penetration. The trial's focus on modifiable risk factors aligns with current trends in preventive medicine, suggesting a favorable environment for commercialization if proven effective.
Indication: Alzheimer Disease
Modality: behavioral intervention
Target: Personalized health behavior modification strategies aimed at reducing Alzheimer's disease risk factors.
Sponsor: Rhode Island Hospital
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 15, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Personalized health behavior modification strategies aimed at reducing Alzheimer's disease risk factors.
View original source fields
Condition raw: Alzheimer Disease
Condition normalized: Alzheimer Disease
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Personalized health behavior modification strategies aimed at reducing Alzheimer's disease risk factors.
Target normalized: Personalized health behavior modification strategies aimed at reducing Alzheimer's disease risk factors.